106 related articles for article (PubMed ID: 23334935)
1. Thermotherapy using magnetic cationic liposomes powerfully suppresses prostate cancer bone metastasis in a novel rat model.
Kobayashi D; Kawai N; Sato S; Naiki T; Yamada K; Yasui T; Tozawa K; Kobayashi T; Takahashi S; Kohri K
Prostate; 2013 Jun; 73(9):913-22. PubMed ID: 23334935
[TBL] [Abstract][Full Text] [Related]
2. Effect of heat therapy using magnetic nanoparticles conjugated with cationic liposomes on prostate tumor in bone.
Kawai N; Futakuchi M; Yoshida T; Ito A; Sato S; Naiki T; Honda H; Shirai T; Kohri K
Prostate; 2008 May; 68(7):784-92. PubMed ID: 18302228
[TBL] [Abstract][Full Text] [Related]
3. Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune-response induction in transplanted syngeneic rats.
Kawai N; Ito A; Nakahara Y; Futakuchi M; Shirai T; Honda H; Kobayashi T; Kohri K
Prostate; 2005 Sep; 64(4):373-81. PubMed ID: 15754344
[TBL] [Abstract][Full Text] [Related]
4. Complete regression of experimental prostate cancer in nude mice by repeated hyperthermia using magnetite cationic liposomes and a newly developed solenoid containing a ferrite core.
Kawai N; Ito A; Nakahara Y; Honda H; Kobayashi T; Futakuchi M; Shirai T; Tozawa K; Kohri K
Prostate; 2006 May; 66(7):718-27. PubMed ID: 16425185
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles.
Ito A; Shinkai M; Honda H; Yoshikawa K; Saga S; Wakabayashi T; Yoshida J; Kobayashi T
Cancer Immunol Immunother; 2003 Feb; 52(2):80-8. PubMed ID: 12594571
[TBL] [Abstract][Full Text] [Related]
6. Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer.
Johannsen M; Thiesen B; Gneveckow U; Taymoorian K; Waldöfner N; Scholz R; Deger S; Jung K; Loening SA; Jordan A
Prostate; 2006 Jan; 66(1):97-104. PubMed ID: 16114060
[TBL] [Abstract][Full Text] [Related]
7. Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study.
Shinkai M; Yanase M; Honda H; Wakabayashi T; Yoshida J; Kobayashi T
Jpn J Cancer Res; 1996 Nov; 87(11):1179-83. PubMed ID: 9045948
[TBL] [Abstract][Full Text] [Related]
8. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
Johannsen M; Thiesen B; Jordan A; Taymoorian K; Gneveckow U; Waldöfner N; Scholz R; Koch M; Lein M; Jung K; Loening SA
Prostate; 2005 Aug; 64(3):283-92. PubMed ID: 15726645
[TBL] [Abstract][Full Text] [Related]
9. Targeted hyperthermia using magnetite cationic liposomes and an alternating magnetic field in a mouse osteosarcoma model.
Shido Y; Nishida Y; Suzuki Y; Kobayashi T; Ishiguro N
J Bone Joint Surg Br; 2010 Apr; 92(4):580-5. PubMed ID: 20357339
[TBL] [Abstract][Full Text] [Related]
10. Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes.
Yanase M; Shinkai M; Honda H; Wakabayashi T; Yoshida J; Kobayashi T
Jpn J Cancer Res; 1998 Jul; 89(7):775-82. PubMed ID: 9738985
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma.
Ito A; Matsuoka F; Honda H; Kobayashi T
Cancer Immunol Immunother; 2004 Jan; 53(1):26-32. PubMed ID: 14551746
[TBL] [Abstract][Full Text] [Related]
12. Intracellular hyperthermia for cancer using magnetite cationic liposomes: ex vivo study.
Yanase M; Shinkai M; Honda H; Wakabayashi T; Yoshida J; Kobayashi T
Jpn J Cancer Res; 1997 Jul; 88(7):630-2. PubMed ID: 9310134
[TBL] [Abstract][Full Text] [Related]
13. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy.
Zheng C; Zheng M; Gong P; Deng J; Yi H; Zhang P; Zhang Y; Liu P; Ma Y; Cai L
Biomaterials; 2013 Apr; 34(13):3431-8. PubMed ID: 23375952
[TBL] [Abstract][Full Text] [Related]
14. [Hyperthermia for therapy of brain tumors by means of magnetite cationic liposomes].
Watabayashi T; Nakahara N; Yoshida J
Nihon Rinsho; 2005 Sep; 63 Suppl 9():490-4. PubMed ID: 16201569
[No Abstract] [Full Text] [Related]
15. Magnetic nanoparticle hyperthermia for prostate cancer.
Johannsen M; Thiesen B; Wust P; Jordan A
Int J Hyperthermia; 2010; 26(8):790-5. PubMed ID: 20653418
[TBL] [Abstract][Full Text] [Related]
16. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
[TBL] [Abstract][Full Text] [Related]
17. Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models.
Festuccia C; Gravina GL; D'Alessandro AM; Muzi P; Millimaggi D; Dolo V; Ricevuto E; Vicentini C; Bologna M
Endocr Relat Cancer; 2009 Jun; 16(2):401-13. PubMed ID: 19153211
[TBL] [Abstract][Full Text] [Related]
18. Combination of non-viral connexin 43 gene therapy and docetaxel inhibits the growth of human prostate cancer in mice.
Fukushima M; Hattori Y; Yoshizawa T; Maitani Y
Int J Oncol; 2007 Jan; 30(1):225-31. PubMed ID: 17143533
[TBL] [Abstract][Full Text] [Related]
19. High efficacy of docetaxel with and without androgen deprivation and estramustine in preclinical models of advanced prostate cancer.
Fizazi K; Sikes CR; Kim J; Yang J; Martinez LA; Olive MC; Logothetis CJ; Navone NM
Anticancer Res; 2004; 24(5A):2897-903. PubMed ID: 15517894
[TBL] [Abstract][Full Text] [Related]
20. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
